Emmanuel DONNADIEU

Working in the field of immunology for more than 20 years, Dr. Donnadieu (54 y/o) has accumulated a thorough experience in cell signaling and cellular imaging related to T cell physiology. He is particularly well recognized in the field of T cell migration and the role played by external factors controlling this process. He is group leader since 2014, DR2 CNRS since 2012. Meetings: He was invited speaker in the 6th Immunotherapy of Cancer Conference (ITOC) (Vienna, Austria) 2019, Protein & Antibody Engineering Summit (Lisbon, Portugal) 2018, International Conference on Immunology, Immunodeficiency and Immunotherapy (Freiburg, Germany) 2018, American Association for Cancer Research Annual Meeting (San Diego, USA) 2014. He gave more than 20 invited seminars. Grants: Team Labeled Ligue contre le cancer (2020-2022), EU H2020 CARAT (2016-2019), Plan Cancer THE PROGRAM (2016-2019), INCA PLBIO (2016-2019), Team Labeled Ligue contre le cancer (2013-2015). Publications: 55 peer-review articles (H Index 29), including last author in J Exp Med 2007, J Clin Invest 2012, PNAS 2x in 2018; 11 reviews; 2 book chapters; Associate Editor for The Journal of Immunology since 2018.